CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+56.41%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.76B
AUM Growth
+$1.76B
Cap. Flow
-$130M
Cap. Flow %
-7.41%
Top 10 Hldgs %
61.02%
Holding
81
New
8
Increased
13
Reduced
7
Closed
19
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CNTA
51
Centessa Pharmaceuticals
CNTA
$2.13B
$3.48M 0.19%
561,600
LPTX icon
52
Leap Therapeutics
LPTX
$12M
$3.36M 0.19%
1,073,046
-408,465
-28% +$2.89M
OCUL icon
53
Ocular Therapeutix
OCUL
$2.25B
$3.33M 0.19%
+645,000
New +$3.33M
GRNA
54
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$2.74M 0.15%
9,188,659
GLTO icon
55
Galecto
GLTO
$3.93M
$2.57M 0.14%
1,020,238
BHVN icon
56
Biohaven
BHVN
$1.71B
$1.96M 0.11%
81,963
AUTL
57
Autolus Therapeutics
AUTL
$383M
$933K 0.05%
392,167
LENZ
58
LENZ Therapeutics
LENZ
$1.12B
$519K 0.03%
199,547
HARP
59
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$384K 0.02%
540,600
BCEL
60
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$313K 0.02%
319,057
ORTX
61
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$134K 0.01%
25,664
RXDX
62
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-1,655,000
Closed -$178M
VECT
63
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
-2,536,617
Closed -$21.6M
ISEE
64
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
0
RAIN
65
DELISTED
Rain Oncology Inc. Common Stock
RAIN
-2,978,660
Closed -$26M
ICVX
66
DELISTED
Icosavax, Inc. Common Stock
ICVX
-643,825
Closed -$3.73M
PSTX
67
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-1,000,000
Closed -$3.08M
XFOR icon
68
X4 Pharmaceuticals
XFOR
$70M
-1,628,980
Closed -$1.42M
VKTX icon
69
Viking Therapeutics
VKTX
$3.02B
-1,050,000
Closed -$17.5M
TRML icon
70
Tourmaline Bio
TRML
$645M
-900,649
Closed -$1.69M
TNGX icon
71
Tango Therapeutics
TNGX
$745M
-4,116,949
Closed -$16.3M
PYXS icon
72
Pyxis Oncology
PYXS
$91.2M
-272,537
Closed -$1.09M
PRME icon
73
Prime Medicine
PRME
$595M
-734,350
Closed -$9.03M
PLRX icon
74
Pliant Therapeutics
PLRX
$105M
-1,444,000
Closed -$38.4M
GLUE icon
75
Monte Rosa Therapeutics
GLUE
$309M
-2,893,717
Closed -$22.5M